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http://dx.doi.org/10.1016/j.stemcr.2017.04.028SUMMARYIn themicrocirculation, pericytes are believed to function asmesenchymal stromal cells (MSCs).We hypothesized that the vasa vasorum
harbor progenitor cells within the adventitia of human aorta. Pericytes, endothelial progenitor cells, and other cell subpopulations were
detected among freshly isolated adventitial cells using flow cytometry. Purified cultured pericytes were enriched for the MSC markers
CD105 and CD73 and depleted of the endothelial markers vonWillebrand factor and CD31. Cultured pericytes were capable of smooth
muscle lineage progression including inducible expression of smoothmusclemyosin heavy chain, calponin, and a-smoothmuscle actin,
and adopted a spindle shape. Pericytes formed spheroids when cultured onMatrigel substrates and peripherally localized with branching
endothelial cells in vitro. Our results indicate that the vasa vasorum form a progenitor cell niche distinct from other previously described
progenitor populations in human adventitia. These findings could have important implications for understanding the complex patho-
physiology of human aortic disease.INTRODUCTION
Just as the circulatory system provides nourishment to sup-
port tissue and organ function, the larger blood vessels
themselves require access to a blood supply to maintain
vascular health. The vasa vasorum (Latin: ‘‘vessels of the
vessels’’) serve this vital role in large blood vessel homeosta-
sis. In the ascending thoracic aorta, the microvascular
network of vasa vasorum is particularly rich (Heistad
et al., 1981). Here, the vasa vasorum originate from the cor-
onary and brachiocephalic arteries and represent a contin-
uum of the epicardium (Heistad et al., 1981). Vasa vasorum
penetrate the adventitial layer and provide nourishment to
the media of large blood vessels (>0.5 mm thick) with
greater than 29 elastic lamellae at birth such as the thoracic
aorta, pulmonary artery, and saphenous vein of humans,
sheep, and canines (Wolinsky and Glagov, 1967). The
vasa vasorum deliver oxygen and nutrients to and remove
waste from the outer two-thirds of the medial layer while
the inner media is fed from the lumen. First-order, larger
(>100 mm) vessels run longitudinally along the host vessel
and branch into second-order, smaller (<100 mm) vessels
that penetrate the adventitia and into the medial layer
(Kwon et al., 1998). Since the first realization of this dy-
namic microvascular network by Koester over 150 years
ago (Koester, 1876), the role of the vasa vasorum in large-
vessel homeostasis and disease states has been relatively
undefined. While the adventitia provides the majority of292 Stem Cell Reports j Vol. 9 j 292–303 j July 11, 2017 j ª 2017 The Autho
This is an open access article under the CC BY-NC-ND license (http://creativbiomechanical support to the vessel, new roles for the
adventitia and vasa vasorum in vascular homeostasis,
injury response, and disease are actively emerging (Havelka
and Kibbe, 2011; Majesky, 2015).
Cells isolated from the microvasculature of vascularized
tissues such as skeletal muscle, fat, placenta, and pancreas
have been shown to be capable of multi-lineage differenti-
ation, localized to small arterioles within these tissues, and
characterized as pericytes (Chen et al., 2013; Corselli et al.,
2011; Crisan et al., 2012, 2008a, 2008b; Park et al., 2011;
Traktuev et al., 2008; Zimmerlin et al., 2010). Analogous
to these small blood vessels that feed tissues is the perivas-
cular network of the vasa vasorum associated with large
blood vessels. While multi-potential progenitors have
been isolated from the adventitia of human pulmonary ar-
tery (Hoshino et al., 2008), human internal thoracic artery
(Klein et al., 2011; Zengin et al., 2006), human fetal aorta
(Invernici et al., 2007), human saphenous vein (Campag-
nolo et al., 2010), and human adult ascending aorta (Pas-
quinelli et al., 2007, 2010), these cells uniformly exist
within a ‘‘zone of vasculogenesis’’ (Zengin et al., 2006),
and are distinct from the vasa vasorum. To our knowledge,
no prior study has investigated a progenitor cell population
associated with the vasa vasorum specifically in the human
adult aorta as a progenitor cell repository. This question has
been addressed only in animal models, where cells report-
edly isolated from explants of vasa vasorum in the aorta
of the adult rat exhibited differentiation toward thers.
ecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Representative H&E-Stained
Cross-Section of Human Ascending Aorta
All three layers of the aortic wall: adventitia
(adv), media (med), and intima (int).
Dashed line indicates adv/med border.
Inset shows a higher magnification of the
adventitial area where vasa vasorum are
located (arrowheads). Scale bar, 250 mm.neuronal lineage (Montiel-Eulefi et al., 2012), and the post-
natal rat aorta was shown to contain pericyte progenitor
cells (Howson et al., 2005). We hypothesized that the
vasa vasorum harbor progenitor cells within the adventitia
of human aorta. In the present study, we documented the
presence of several subpopulations of perivascular progen-
itor cells. We report successful purification and expansion
of functional pericytes ex vivo that can differentiate toward
the smooth muscle lineage. Our findings of vasa vasorum-
associated progenitor cell subsets in human thoracic aorta
could have important implications in the study and treat-
ment of large-vessel diseases involving vasa vasorum in
humans.RESULTS
Vasa Vasorum-Associated Cells in Human Adult
Thoracic Aorta Natively Express Markers of Progenitor
Cells
We sought the in situ location of cells expressingmarkers of
progenitor, smooth muscle, pericyte, and endothelial cells
in human aortic adventitia. Vasa vasorum of all sizes in the
adventitia were evaluated (Figure 1). As expected, cells ex-
pressing a pericyte marker profile were found to be local-
ized to the vasa vasorum in the adventitia of human aorta.
Immunohistochemical analysis of transverse full-thickness
sections of human adult ascending thoracic aorta revealed
a population of pericytes (CD146+/a-SMA±/NG2+/CD34/vWF) surrounding endothelial cells (a-SMA/CD34±/
CD31+/vWF+) associated with smaller vessels of the vasa
vasorum (<25 mm) (Figure 2). A subset of CD146+ cells co-
expressed a-smooth muscle actin (a-SMA) (Figure 2A) in a
perivascular location adjacent to vWF+ (von Willebrand
factor) (Figures 2B and 2C) and CD34+ endothelial cells
(Figure 2D). Subsets of pericytes (a-SMA+/CD31) ex-
pressed CD34 (Figures 2E–2G) and a subset of CD31+ cells
also co-expressed CD34 in the endothelium (Figure 2G).
NG2 was expressed by SMA+ pericytic cells (Figure 2H).
Expression of CD105, a marker found on mesenchymal
stromal cells (MSCs), was noted in pericytes and endothe-
lial cells of vasa vasorum (Figure 2I). Another noted popu-
lation of interest included CD34+/a-SMA cells that were
situated superficially to vasa vasorum, which we have
deemed ‘‘supra-vasa’’ cells (Figure 2J). CD34+/a-SMA su-
pra-vasa cells were found to lack CD146 (Figure 2K) and
co-express CD90 (Figure 2L). These findings are representa-
tive of five patient specimens analyzed.Flow-Cytometry Characterization of Perivascular
Progenitor Cell Surface Proteomes in Human Adult
Thoracic Aortic Adventitia
Analytical flow cytometry of freshly isolated adventitial
cells from seven human ascending thoracic aortas (Fig-
ure 3A) confirmed the presence of multiple distinct
subpopulations of cells from all live events (Figure 3B).
Non-hematopoietic (NH) cells were gated on the basis ofStem Cell Reports j Vol. 9 j 292–303 j July 11, 2017 293
Figure 2. Immunodetection of Vasa Vasorum-Associated Cell Populations in Human Aorta
Sections of human aorta were immunolabeled using markers of progenitor cells andmarkers of the smooth muscle and endothelial lineages.
An asterisk denotes the lumen of described vessels, and nuclei appear in blue in all panels. All representative vessels in all panels were
selected above the adventitial/media border within respective sections.
(A) Transverse sections of small-diameter vessels (<25 mm) of the vasa vasorum in the adventitia displayed co-expression of CD146+ (red)
with the smooth muscle marker a-SMA (green, open arrows) amid CD146+ cells lacking a-SMA expression (arrow).
(B) CD146+ cells (red, arrows) surrounded vWF+ endothelial cells (green) lining in small-diameter vessels (<25 mm).
(C) Longitudinal view of CD146+ pericytes (red, arrow) wrapping vWF+ endothelial cells (green).
(D) CD146+ pericytes (green, open arrow) surrounded CD34+ endothelial cells (red, arrow) of the vasa vasorum.
(E) A small vasa vasorum (<25 mm) revealing expression of CD34 (green, arrows) in CD31 peri-endothelial cells. Endothelial cells are
CD31+ (red).
(F) Serial section adjacent to the section in (E) shows co-expression of CD34+ (green) with SMA (red, arrow) in pericytes surrounding
a-SMA endothelial cells.
(G) CD34 (green) was expressed in subsets of CD31+ (red, open arrow) endothelial cells and in CD31 pericytes (arrows).
(H) NG2 was expressed in a-SMA cells (red, open arrow) and co-expressed in a-SMA+ cells (green, arrow) in vasa vasorum vessels <25 mm.
(I) CD105 immunolabeling (red, arrow) revealed co-expression a-SMA+ pericytes and in endothelial cells.
(J) CD34+/SMA cells were located in the endothelium (red, arrow) and surrounding a-SMA+ cells (green) in the periphery of vasa vasorum
(open arrows).
(K) A serial section of the image shown in (J) revealed SMA cells (open arrows) in the same supra-vasa location as CD34+ cells shown in (J)
surrounding CD146+/SMA+ cells of the vasa vasorum.
(L) CD90 (red, open arrows) was also detected in a-SMA cells located in the periphery of vasa vasorum a-SMA+ cells (green) and in
endothelial cells (arrow).
Results shown are one representative of five independent patient specimens examined. Scale bars, 25 mm (A–H and J–L) and 10 mm (I).absent CD45 expression amid absence of CD56 (Figure 3C,
middle panel) and further analyzed on the basis of CD34
and CD31 expression. Freshly isolated adventitial cells
from adult human aorta included a population of cells
that exhibited a pericyte profile of CD146+/CD34/
CD31 and were found to comprise 3.83% ± 1.23% of all
NH cells in the adventitia (Figure 3C [lower left panel]294 Stem Cell Reports j Vol. 9 j 292–303 j July 11, 2017and Table 1). Most of these pericytes expressed CD90
(74.78% ± 8.17%). When a gating strategy indiscriminant
of CD34 was applied to CD56/CD45/CD31 cells (as dis-
played in Table 1), we found that an appreciable number of
CD146+/CD31 cells co-expressed CD34 (15.4% ± 5.87%)
while another, slightly smaller subset co-expressed CD90
and CD34 (10.59% ± 4.2%).
Figure 3. Classification of Adventitial
Cell Populations in a Representative Pa-
tient Specimen via Multi-dimensional
Analytical Flow Cytometry
(A) The adventitia (top layer) was de-
laminated from the aorticmedia (lower layer)
and processed for isolation of primary cells.
(B) Detection of all events and all nucleated
cells (denoted as A) using forward scatter
(FSC) and DAPI in fixed and gently per-
meabilized cells to detect events withR2N.
(C) Classification of nucleated events
identified in (B) into subpopulations. First,
a non-hematopoietic population ([NH]) of
CD45/CD56 cells was established from
the parent gate ([A]) (top middle panel).
Next, the [NH] gate (center panel) was
utilized to delineate four distinct cell sub-
populations (four flanking panels): endo-
thelial mature ([EM]) were classified as
CD31+/CD34 (top left panel); endothelial
progenitor ([EP]) were classified as CD31+/
CD34+ (top right panel); pericytes ([P])
were classified as CD146+/CD34/CD31
(bottom left panel); and supra-vasa ([SV])
were classified as CD146/CD31/CD34+
(bottom right panel). Solid-line boxes de-
pict selected gates, and numbers within
each profile represent counts within each
noted gate. Each panel depicts a represen-
tative light-scatter profile for the candidate
population from one representative patient
specimen of seven independent patient
specimens analyzed. Prevalence of each
subpopulation was quantified from seven
independent patient specimens was char-
acterized further.
See also Table 1.CD34+ cells characterized by the surface marker pro-
file CD146/CD56/CD45/CD34+/CD31 were found to
be more abundant than CD146+/CD31 pericytes and
comprised 32.75% ± 6.82%ofNH adventitial cells (Table 1).
These cellswere considered to benon-endothelial cells since
they lacked CD31 expression andwere consistent with cells
localized in native adventitia in the periphery of vasa vaso-
rum, the so-called supra-vasa cells described above in aortic
tissue sections. Most of these supra-vasa cells also co-ex-
pressed CD90 (71.24% ± 9.28%). Mature endothelial cells
expressing the profile of CD56/CD45/CD34/CD31+
comprised 1.69% ± 0.99% of NH cells in the adventitia
(Table 1).We considered these cells to bemature endothelial
cells due to their lack ofCD34 expression. About one-fifth of
these mature endothelial cells expressed CD146 (19.79% ±
13.14%) whereas only about one-tenth expressed CD90
(9.20% ± 3.40%). Cells lacking CD34, CD146, and CD90represented a majority (74.60% ± 12.39%) of CD31+ endo-
thelial cells (Table 1). A cell subset was considered
committed to endothelial lineage or in a progenitor state
on the basis of CD31 expression alone or CD31 co-expres-
sionwithCD34, respectively. TheseCD34+/CD31+endothe-
lial progenitor cells (EPCs) were fairly abundant in aortic
adventitia and, on average, comprised 8.29% ± 3.49% of
all NH cells (Table 1). About half of the EPCs expressed
CD146 (53.45% ± 4.94%) while about one-third co-ex-
pressed CD90 (32.08% ± 5.37%), which was appreciably
more than the proportion of CD90+ cells in the endothelial
mature (CD34/CD31+) fraction (9.20% ± 8.99%).
Profile of Ex Vivo Expanded Perivascular Subsets
The ex vivo phenotype of cultured cells displaying the peri-
cyte profile of CD146+/CD90+/CD56/CD45/CD34/
CD31 were evaluated from human adventitia of threeStem Cell Reports j Vol. 9 j 292–303 j July 11, 2017 295













Mean SD SEM Mean SD SEM Mean SD SEM Mean SD SEM
Nucleated cells (%) 0.65 0.81 0.31 3.86 2.32 0.88 0.23 0.35 0.13 0.90 0.97 0.37
Non-heme (%) 3.83 3.25 1.23 32.75 18.04 6.82 1.69 2.62 0.99 8.29 9.23 3.49
CD146+ (%) 100 – – 0 – – 19.79 34.76 13.14 53.45 13.08 4.94
CD34+ (%) 15.40 15.52 5.87 100 – – 0 – – 100 – –
CD90+ (%) 74.78 21.63 8.17 71.24 24.56 9.28 9.20 8.99 3.40 32.08 14.22 5.37
CD90+/CD34+ (%) 10.59 11.12 4.2 71.24 24.56 9.28 0 – – 32.08 14.22 5.37
CD146/CD90 (%) 0 – – 28.76 24.56 9.28 74.60 32.78 12.39 32.65 11.71 4.43independent patients using fluorescence-activated cell
sorting (FACS) (Figure 4A). Sorted pericytes exhibited
uniform elongated cell morphology (Figure 4B). Not sur-
prisingly, the adventitia of human aorta was noted to be
a highly heterogeneous microenvironment with many
cell types, as evidenced by detection of gene transcripts
from several cell types including smooth muscle cells
(SMCs) (CD146 and CNN), endothelial cells (CD31 and
VWF), pericytes (CD146), and MSCs (CD73, CD90, and
CD105) (Figures 4C–4 J). To confirm the phenotypic profile
of FACS-purified adventitial cells sorted on the pericyte sur-
face proteome of CD146+/CD90+/CD56/CD45/CD34/
CD31, qPCR analysis revealed enriched expression of
the pericyte markers CD146, the mesenchymal stem cell
markers CD73 and CD105, and depleted expression of
the hematopoietic marker CD45 and endothelial markers
CD31 and vWF when compared with native adventitia, as
expected. There were similar levels of CD90 and CNN
gene expression noted in both the parent adventitia spec-
imen and sorted pericytes.
FACS-purified pericytes maintained in their basal
culture medium displayed minimal and heterogeneous
expression of CNN and a-SMA with minimal co-expres-
sion of these SMC markers. Smooth muscle myosin
heavy chain (SM-MHC) was not detected in pericytes
under basal growth conditions (Figure 4K). Under
transforming growth factor b1 (TGF-b1) and platelet-
derived growth factor BB (PDGF-BB) stimulation in
growth medium, most sorted pericytes acquired SM-
MHC expression, revealed an increased number of cells
expressing SM-MHC or a-SMA with CNN, and adopted
a spindle-like morphology when compared with cells
cultured in the absence of TGF-b1 and PDGF-BB (Fig-
ure 4K). However, the proportion of pericytes co-express-
ing CNN with either a-SMA or SM-MHC did not appear
to change under TGF-b1 and PDGF-BB stimulation
(Figure 4K).296 Stem Cell Reports j Vol. 9 j 292–303 j July 11, 2017Functional Evaluation of Sorted Pericytes In Vitro
To assess the ability of primary cultured pericytes to
participate in vasculogenesis, we employed an in vitro
endothelial branching assay using the culture substrate
GFR-Matrigel. After 24 hr of culture, endothelial cells
from human pulmonary artery formed branched networks
on Matrigel (Figure 5A). Within 1–2 hr of initial seeding
on Matrigel-coated tissue culture surfaces, sorted peri-
cytes briefly exhibited extensions and then spontaneously
assembled into spheroid colonies within 6 hr (Figure 5B
and Movie S1). When pericytes were co-cultured with
endothelial cells, they localized on the periphery of
branching endothelial cells (Figure 5C, arrows). Spheroid
cultures of pericytes sprouted cellular offshoots that
continued to expand over 5 days and extend cell processes
between cell clusters (Figures 5D and 5E).DISCUSSION
The adventitia of ascending thoracic aorta is a rich bed of
vasa vasorum and represents a specialized perivascular
niche. Here, we classified adventitial cells within human
adult thoracic aorta as progenitor cell subsets using their
antigenic profile, function, and native location associated
with the microvascular network of the vasa vasorum, and
characterized their potential for smooth muscle lineage
progression.
It has been shown that vasa vasorum of human arteries
contain pericyte-like cells (Andreeva et al., 1998), and we
demonstrate that vasa vasorum-associated pericytes from
the adventitia of human adult aorta (CD146+/CD90+/
CD34/CD31) were similar in marker profile to pericytes
characterized in small arterioles of several other vascular-
ized tissues (Crisan et al., 2008c). Our findings in human
vasa vasorum are consistent with the prior work of others
who identified that CD146 co-expressed on the surface of
Figure 4. Characterization of FACS-Isolated Pericyte Populations
(A) Pericytes were isolated using multi-dimensional FACS on the basis of a surface proteome of CD146+/CD90+/CD56/CD45/CD34/
CD31. DAPI was used to discriminate live from dead/apoptotic cells (far left panel). Cells were first gated for exclusion of CD45 and CD56
(second panel), followed by exclusion of CD31 and CD34 (third panel), and finally for expression of CD146 and CD90 (far right panel).
(B) Bright-field micrograph of sorted pericytes in culture. Scale bar, 100 mm.
(C–J) Pooled real-time qPCR analysis in total RNA isolated from adventitia tissue (n = 5 independent patient specimens) and in vitro
cultivated sorted pericytes (n = 3 independent patient specimens) revealed that sorted pericytes were enriched for transcript expression of
the pericyte marker CD146 (C), had equivalent expression of the mesenchymal stem cell markers CD90 (D), and increased expression of
CD105 (E) and CD73 (F). Sorted pericytes expressed smooth muscle marker CNN, similar to that of all native adventitial cells (G), and were
depleted of expression for the hematopoietic lineage marker CD45 (H) and endothelial lineage markers CD31 (I) and VWF (J). Error bars
represent mean ± SEM. *p < 0.05.
(K) Sorted pericytes cultured in the presence of TGF-b1 and PDGF (right panels) adopted a spindle-shaped morphology, and the number of
cells positive for markers of the smooth muscle lineages including expression of SM-MHC, a-SMA, and Cnn was increased. Control cells (left
panels) maintained in their normal growth medium had a rhomboid morphology, lacked appreciable SM-MHC a-SMA and Cnn expression.
Scale bar, 50 mm.
See also Table S1.NG2+ pericytes (Crisan et al., 2008c; Sacchetti et al., 2007)
and with studies revealing expression of the progenitor
markers nestin and Wilms’ tumor protein on small
(<50 mm) vasa vasorum in healthy human abdominal aortaand iliac, femoral, and renal arteries (Vasuri et al., 2012).
CD146 has been detected in the endothelium of vessels
in tissues (Duda et al., 2006), and using multi-parameter
analytical flow cytometry, we detected co-expression ofStem Cell Reports j Vol. 9 j 292–303 j July 11, 2017 297
Figure 5. Functional Analysis of Sorted
Pericytes and Endothelial Cells from Hu-
man Aortic Adventitia
(A) Human endothelial cells from pulmonary
artery form branching networks on the
surface of Matrigel substrates. Scale bar,
100 mm.
(B) Sorted human adventitia-derived peri-
cytes cultured on the surface of Matrigel
spontaneously form spheroid cultures within
4–6 hr. Scale bar, 100 mm.
(C) Sorted pericytes (green, arrows) associ-
ated in the periphery of branching endo-
thelial cells (red). Scale bar, 100 mm.
(D) Spheroids of pericytes in culture alone
on Matrigel expanded over 5 days. Scale
bar, 50 mm.
(E) Anastomoses between cell clusters ex-
panding from spheroids within 5 days. Scale
bar, 100 mm.
Results shown are representative of three
independent experiments. See also Movie S1.CD146 on CD31+ cells, especially in cells that were also
positive for CD34, which have been described as EPCs
(Zimmerlin et al., 2010). While our ex vivo cultivated peri-
cytes were sorted exclusively of CD34+ cells, others have
characterized cells co-expressing CD146 and CD34 as peri-
cytes (Traktuev et al., 2008) and have suggested that these
cells may be transitory between CD146/CD34+ adventi-
tial cells (Zimmerlin et al., 2010) and CD146+/CD34 peri-
cytes, since CD34+ adventitial cells have been shown to be
progenitors of pericytes (Corselli et al., 2011). Confirming298 Stem Cell Reports j Vol. 9 j 292–303 j July 11, 2017this prior finding was our detection of CD34 expression
in a-SMA+ pericytes of small-diameter (<25 mm) vasa vaso-
rum, and we noted their prevalence in human aortic
adventitia to be, on average,15% of non-endothelial cells
defined by the surface marker profile of CD146+/CD56/
CD45/CD31. Thus, CD34+ pericytes in human adventi-
tial vasa vasorum are not as prevalent as those described
for the stromal vascular fraction in adipose tissue, where
others have reported prevalence of CD34+ pericytes of up
to 32% (Zimmerlin et al., 2010). CD34+ cells within adipose
Table 2. Respective Differentiation Potential of Progenitor Cell Populations in Human Adult Tissues: Examples from the Literature
Subpopulation Surface Proteome Differentiation Potential
Pericyte CD146+/CD34/CD31 muscle (Crisan et al., 2008c; Park et al., 2011), bone (Crisan et al., 2008c),
cartilage (Crisan et al., 2008c), fat (Zimmerlin et al., 2010), myocardium
(Chen et al., 2013)
Adventitial cells/supra-vasa CD34+/CD31 bone (Pasquinelli et al., 2010), cartilage (Pasquinelli et al., 2010), fat
(Pasquinelli et al., 2010; Zimmerlin et al., 2010), smooth muscle/pericyte
(Campagnolo et al., 2010; Corselli et al., 2011), endothelial (Pasquinelli
et al., 2007; Zengin et al., 2006)
Endothelial progenitor CD34+/CD31+ endothelial (Aicher et al., 2007; Kirton and Xu, 2010), fat (Zimmerlin
et al., 2010)
Endothelial mature CD34/CD31+ endMT (Medici et al., 2010), fat (Zimmerlin et al., 2010)
endMT, endothelial to mesenchymal transition.tissue have been described as pericytes, since they ex-
hibited both a surface marker profile and in vivo location
indicative of pericytes as well as functionality to co-localize
with branching endothelial cells in vitro (Traktuev et al.,
2008). Hence, there appears to be heterogeneity in both
the surface proteome and prevalence of pericytes across tis-
sues. We also noted CD34+ stromal cells, which were non-
endothelial (CD31) and non-pericytic (CD146), and
were so named due to their location in the periphery of
vasa vasorum arterioles and their similarity in marker pro-
file and location to other perivascular cells in white adipose
tissue (Corselli et al., 2011; Zimmerlin et al., 2010). Our pre-
sent findings corroborate the work of West et al. (2016),
who characterized the stromal vascular fraction in a large
cohort of human adipose tissue collected from multiple
centers using flow cytometry, and reported that pericytes
(CD45/CD146+/CD34) and adventitial cells (CD45/
CD146/CD34+) have a prevalence of 8% and 33%, respec-
tively, and together represent subpopulations of perivascu-
lar stem cells (West et al., 2016).
The FACS-purified and cultivated pericytes described in
the present study along with those described by others
who documented MSC-like behavior of pericytes do not
appear to be the same as mesodermal progenitor cells
(MPCs) (Caplan, 2008; Crisan et al., 2008c), a subset of
MSCs in human bone marrow-derived populations that
were shown to exhibit angiogenic potential (Petrini et al.,
2009). Localization of our ex vivo cultured pericytes
alongside branching endothelial cells in vitro is character-
istic of other pericytic populations (Mayo and Bearden,
2015) and distinguishes our aortic-derived pericytes from
MPCs. Furthermore, the capacity of these aortic adventi-
tial-derived pericytes to form spontaneous spheroids and
subsequent sprouting has not been previously reported
for similar cell types. A lack of CD34 and CD31 expression
on our sorted adventitia-derived pericytes defines them as a
population altogether distinct from MPCs, MSCs derivedfrom CD34+ adventitial cells (Corselli et al., 2011; West
et al., 2016; Zimmerlin et al., 2010), and CD34+ supra-
vasa cells described herein by our group.
Several vascularized tissues of fetal and adult origin such
aswhite adipose, lung, pancreas,muscle, and placentawere
all found to harbor cells capable of multi-lineage differenti-
ation (Caplan, 2008; Corselli et al., 2011; Crisan et al.,
2008c); and a recent study challenges the notion of a uni-
versal MSC by conversely showing that populations of cells
in multiple tissues and organs with similar surface marker
profiles differ broadly in their in vivo potential (Sacchetti
et al., 2016). Since the aortic adventitia is associated
with peri-adventitial adipose and human pericytes isolated
from stromal vascular fraction of white adipose tissue
(Zimmerlin et al., 2010) both exhibited high adipogenic
potential, one could reasonably question whether the cells
described in our study are adipose stem cells (ASCs). ASCs
exhibit basal and TGF-b1-inducible expression of a-SMA
(Lee et al., 2006), and pericytes may represent progeny of
a subset of ASCs (Baer, 2014). In contrast to our sorted peri-
cytes, ASCs have also been described in situ as CD34-ex-
pressing cells that lack expression of a-SMA, CD146, and
CD105 (Baer, 2014). Therefore, the CD34+/CD146 cells
we classified as supra-vasa are the more likely candidates
to be considered ASCs, and populations from the stromal
vascular fraction with identical reported surface proteomes
were previously shown to be adipogenic, albeit not as
potently as the pericyte fraction (Zimmerlin et al., 2010).
Indeed, as summarized in Table 2, similar populations in
human adult specimens of blood vessels and other vascu-
larized tissues have been shown to have multi-lineage po-
tential, like MSCs. Several highly analogous cell popula-
tions in other human adult blood vessels have been
shown to be SMC/pericyte progenitors and exhibited pro-
pensity for adipogenic, chondrogenic, and osteogenic line-
age progression (Klein et al., 2011). Furthermore, several
studies of human fetal tissues (Invernici et al., 2007) andStem Cell Reports j Vol. 9 j 292–303 j July 11, 2017 299
in large (Zaniboni et al., 2014) and small animal models
(Howson et al., 2005; Hu et al., 2004) have contributed
important knowledge regarding the identity, location,
and function of MSCs and other perivascular cell subsets.
Curiously, recent fate-mapping interrogations in mouse
could not find any appreciable contribution of pericytes
and SMCs to other lineages during aging or induced disease
states (Guimara˜es-Camboa et al., 2017). On the contrary,
others revealed that adventitial cells co-expressing Sca-1,
CD34, and Gli1 contribute to atherosclerotic lesions in
the intima in ApoE/mice (Hu et al., 2004). Likewise, Kra-
mann et al. (2016) showed through inducible lineage
tracing that CD34+/Sca1+/Gli1+ adventitial cells differen-
tiate to mature SMCs, migrate to intimal atherosclerotic le-
sions, and localize in close proximity to regions of vascular
calcification in vivo. Since Gli1+ cells co-express CD34 and
lack CD31, they appear to be distinct from our pericytes,
but isolated cells may include a subpopulation of pericytes
or other non-endothelial adventitial cells that partially
share these markers. Future in vivo studies investigating
the fate of our pericytic population in physiological and
pathological settings are required to better appreciate the
potential contribution of vasa vasorum-associated peri-
cytes to other lineages.
The adventitia of large vessels is highly vascularized.
As such, we are not surprised that our multi-parameter
analytical flow cytometric analysis revealed a relatively
high prevalence of cells expressing surface markers consis-
tent with the endothelial lineage, namely CD31. We also
detected CD34 expression in subsets of CD31+ endothelial
cells of adventitial vasa vasorum, which we classified as
EPCs. Still, it is possible that the EPCs from human aortic
adventitia described here may have been derived from the
circulation. The presence of EPCs in the adventitia raises
the question of their potential for neovascularization
and their functionality in the setting of cardiovascular
disease. In the human aorta, cells expressing stem cell
markers STRO-1, CD34, and c-kit have been localized to
the medial layer, even more so in the adventitia, and
were noted to be more prevalent in both layers in cases
of aortic aneurysm and dissection than in normal healthy
aortas (Shen et al., 2012). A purported role for vascular
wall stem cells in vascular disease is currently an area of
intense interest (Nguyen et al., 2013; Tang et al., 2012).
Our current finding of a discrete progenitor cell niche
associated with the adventitial vasa vasorum provides
additional support that these unique cell populations
may play a distinct and important role in thoracic aortic
disease. Although we detected pericytes capable of
smooth muscle lineage progression in both normal and
aneurysmal aorta, we did not compare functional differ-
ences on the basis of disease, and additional work will
help to discern potential differences in surface proteome300 Stem Cell Reports j Vol. 9 j 292–303 j July 11, 2017and functionality of vascular wall progenitors in aortic
disease.
In conclusion, the vasa vasorum and surrounding con-
nective tissue in human adult thoracic aortic adventitia is
a niche for progenitor cell populations. Importantly, their
presence and the demonstrated function of pericytes as
smoothmuscle progenitors and potential for multi-lineage
progression adds to the evolving dichotomy related to
MSCs’ angiogenic potential in vascularized tissues as either
progenitors of endothelial cells or local cells that secrete
angiogenic growth factors in addition to being recruited
to support neovessel formation. The pericyte cultures are
distinct from other prior reports investigating progenitor
cells in the media and adventitia of human thoracic aorta
(Invernici et al., 2007; Pasquinelli et al., 2007, 2010; Shen
et al., 2012) because of their association with the vasa vaso-
rum. Pericytes, adventitial cells, and other perivascular
progenitor cells such as those in the endothelial lineage
associated with the vasa vasorum may influence medial
biology. The function and purpose of these progenitor cells
in the vasa vasorum microenvironment may prove to be
pivotal in the homeostasis and/or remodeling of the aortic
wall in normal or pathologic states.EXPERIMENTAL PROCEDURES
Tissue Collection and Processing
Human ascending thoracic aorta specimens (n = 34 patients) were
collected during elective aortic valve replacement due to valvulop-
athy, from ascending aortic replacement operations due to aneu-
rysm (average aortic diameter was 51.6 ± 5.87 mm [mean ± SD]),
or during heart transplants, with informed patient consent and
approval of the Institutional Review Board at the University of
Pittsburgh under protocol # PRO07020120 and via the Center for
Organ Recovery and Education (Pittsburgh, PA). Upon excision,
tissue specimens were placed on ice and transported to the labora-
tory. Specimens were collected from 28males and 6 females whose
average age was 51.5 ± 14.0 years (mean ± SD).Histology and Immunohistochemistry
Portions (0.5 cm2) of human ascending thoracic aorta specimens
were submerged in OCT medium, frozen over liquid nitrogen,
and stored at 80C prior to cyrosectioning (6 mm). Blocked slides
(5% goat serum, 1 hr) were incubated in primary unconjugated
antibodies: mouse anti-human CD146 (1:50, BD Biosciences,
#550314) or CD34 (1:50, BD Biosciences, #347660), a-SMA
(1:200, DAKO, #M0851 or pre-diluted, Abcam, #15267), CD31
(pre-diluted, DAKO, #M082301-2), CD105 (1:50, Invitrogen,
#MHCD105000), NG2 (1:50, BD Biosciences, #554275), CD90
(1:50, Abcam, #134361) in blocking solution overnight at 4C, or
in conjugated primary antibodies (CD146-Alexa Fluor488, 1:25,
Fisher Scientific, #50-174-931) or vWF-fluorescein isothiocyanate
(FITC) (1:100, US Biological, #V2700-01C) in blocking buffer for
2 hr at room temperature. Secondary labeling was accomplished
with biotinylated goat anti-mouse (1:80, Vector, #BA-9200),
biotinylated goat anti-rabbit (1:80, Vector, #BA-1000), donkey
anti-mouse-Alexa488 (1:250, Jackson Immunoresearch, #115-
545-003), or donkey anti-rabbit-Alexa488 (1:250, Invitrogen,
#A-11008) for 1 hr at room temperature. When necessary, ter-
tiary labeling with streptavidin-Cy3 (1:250, Sigma, #S6402) was
performed. Nuclei were further labeled with DAPI (1:500, Invitro-
gen #D1306) for 30 min at room temperature. Washed slides
were mounted with coverslips using Prolong Gold (Invitrogen,
#P36934) and allowed to dry overnight. Slides were visualized us-
ing a Nikon TE-2000-E2 inverted microscope using bright-field or
epifluorescence microscopy and captured using a CoolSNAP ES2
Monochrome 1,394 3 1,040 High-Resolution Camera (Photomet-
rics) and NIS Elements Software 3.2 (Nikon).Primary Cell Isolation
Primary cells were isolated from 13 independent patient speci-
mens. Upon specimen acquisition in the laboratory within
1–2 hr of harvest, the adventitia was immediately stripped away
from the medial layer and rinsed twice in ice-cold PBS with 1%
penicillin-streptomycin and 1% fungizone (Invitrogen). Tissue
was then finely minced using safety scalpels and rinsed in
PBS and processed further, similar to what we have previously
described (Zimmerlin et al., 2010) (see Supplemental Experimental
Procedures). Isolated primary adventitial cells that were placed
into tissue culture were propagated in basal growth medium
(DMEM, 10% heat-inactivated fetal bovine serum (FBS), 1%
L-glutamine, and 1% penicillin-streptomycin [all from Invitro-
gen]). Gentamycin (Invitrogen) (250 mg/mL) was added for
24–48 hr. Cells weremaintained in a humidified incubation cham-
ber at 37C and 5% CO2 until sufficient numbers were reached to
facilitate FACS (2 passages).Flow Cytometry
Fresh isolates of primary aortic adventitial cells were prepared
as above and their surface marker proteome was subsequently
characterized using analytical flow cytometry without ex vivo cul-
ture, similarly to previously described methods (Zimmerlin et al.,
2010) (see also Supplemental Experimental Procedures).
Freshly isolated primary adventitial cells from eight patients
were separately expanded and subcultured to %70% confluence
for two passages in either basal growth medium (DMEM, 10%
FBS, 1%L-glutamine, and 1%penicillin-streptomycin) or endothe-
lial growth medium in a 37C humidified chamber with 5% CO2
until a population of 0.5–13 107 cells was reached. Cells were im-
munolabeled as described above for analytical flow cytometry.
DAPI was added to unfixed and unpermeabilized cell suspension
just prior to sorting to discriminate live from dead/apoptotic cells.
Cells were sorted using three of a five-laser MoFlo Astrios high-
speed cell sorter (Beckman Coulter, University of Pittsburgh Can-
cer Institute Flow Cytometry Core Facility) enclosed in a Class II
biosafety cabinet. Cells that had been subcultured in basal growth
medium were sorted on the basis of the pericyte surface marker
profile of (CD146+/CD90+/CD56/CD45/CD34/CD31) and
were plated into 6-well plates with basal growth medium supple-
mented with gentamicin and expanded. Medium was replenished
every second day.In Vitro Pericyte Expansion
Sorted pericytes were propagated for one to two passages with me-
dium replenishment every second day and then cryopreserved
in growth medium containing 10% DMSO. Pericytes were then
subcultured in basal growth conditions to confluence. Cells were
cultured in the presence of TGF-b1 (2 ng/mL) and PDGF-BB
(50 ng/mL) to encourage smooth muscle lineage progression for
14 days in commercial smooth muscle cell basal growth medium
(Cell Applications). All growth factors were purchased from R&D
Systems. Cells were cultured in basal growthmedium as a negative
control. Medium was replenished every second day.
RNA Isolation and Real-Time qPCR
Portions of human aortic adventitial specimens were placed in
RNAlater solution (Life Technologies) and stored at 20C until
use. Specimens (15–20 mg) were homogenized in TRIzol reagent
using the gentleMACS Tissue Dissociator (Miltenyi). Cells express-
ing the pericyte profile of CD146+/CD90+/CD34/CD31 under
the parent gate of CD56/CD45 were expanded to P7 and kept
at <70% confluence. Gene expression of CNN, CD146, CD90,
CD31, VWF, CD73, and CD105, were quantified from total RNA
(see also Supplemental Experimental Procedures).
Immunocytochemistry
Sorted pericytes (CD146+/CD90+/CD56/CD45/CD34/CD31)
(P7) were cultured on coverglass under conditions stimulating pro-
gression of the smooth muscle lineage as described above. Cells
were then fixed in 4% paraformaldehyde and analyzed for pheno-
typic markers via immunocytochemical detection of a-SMA, Cnn,
and SM-MHC (see also Supplemental Experimental Procedures).
Endothelial Branching Assay
Sorted pericytes (CD146+/CD90+/CD56/CD45/CD34/CD31)
(passage <8) were maintained in basal growth medium and kept
at <70% confluence. Cells were then seeded at a density of 1.2 3
104 cells/cm2 on growth factor reduced (GFR)-Matrigel (Corn-
ing)-coated 24-well plates in endothelial growth medium on
GFR-Matrigel. Pericytes were also separately seeded on Matrigel
substrates in co-culture in a 1:10 ratio with primary humanpulmo-
nary artery endothelial cells (hPAECs, P8) (Lonza). For co-culture
experiments, populations were labeled with Cell Tracker Green
(pericytes) or Red (hPAECs) (Invitrogen). Cells were cultured at
37C and 5% CO2 in a humidified microscope stage-top incuba-
tion chamber (Tokai Hit). Cells on Matrigel were visualized using
phase-contrast and epifluorescence microscopy on a Nikon TE-
2000-E2 inverted microscope equipped with FITC and tetrame-
thylrhodamine isothiocyanate filter cubes and a 103 objective,
and images were captured every 10 min for up to 50 hr using a
CoolSNAP ES2 Monochrome 1,394 3 1,040 High Resolution
Camera and NIS Elements Software 3.2. Images were also captured
after 1, 3, and 5 days of culture.
Statistical Analyses
Data displayed represent a minimum of three independent exper-
iments performed. Differences in gene expressionwere assessed us-
ing a two-tailed, unpaired Student’s t test. A p value of <0.05 was
considered statistically significant.Stem Cell Reports j Vol. 9 j 292–303 j July 11, 2017 301
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